Description
Wegovy (semaglutide) — a weight‑loss medication is a weight-loss injection from Wegovy, listed for registered Australian clinics in our Weight loss range. Pack: see product images for pack format. Priced in AUD (A$352.00). Sydney dispatch, nationwide. Not a public treatment clinic.
About Wegovy (semaglutide) — a weight‑loss medication
Wegovy (semaglutide) is a weight‑loss medication available as a once‑weekly subcutaneous injection. It helps regulate appetite and reduce calorie intake.
Form and Mechanism of Action
Wegovy is supplied as a solution for subcutaneous injection in pre‑filled pens (2.4 mg, 7.2 mg).
The active ingredient, semaglutide (Semaglutide), is a GLP‑1 receptor agonist that:
- reduces appetite
- slows gastric emptying
- decreases overall food intake
- supports long‑term weight control
Semaglutide acts as an analogue of human GLP‑1 and influences appetite‑regulating centers in the brain, helping reduce caloric consumption.
Structural Characteristics of Semaglutide
The structure of semaglutide is 94% homologous to human GLP‑1, but includes modifications that extend its duration of action:
- substitution of specific amino acids
- fatty‑acid acylation
- resistance to enzymatic degradation
Side Effects and Contraindications
Common side effects include:
- nausea and vomiting
- diarrhea or constipation
- a feeling of heaviness or fullness in the stomach
The medication is contraindicated in individuals with hypersensitivity to semaglutide and in certain medical conditions, including acute pancreatitis. A medical consultation is required before starting therapy.
Effectiveness
When combined with dietary adjustments and physical activity, Wegovy provides significant weight reduction within several weeks. Clinical data confirm sustained weight loss and improved weight control in adults with obesity or overweight.
Wegovy (semaglutide) — a weight‑loss medication — key details for ordering
- Product: Wegovy (semaglutide) — a weight‑loss medication
- Brand: Wegovy
- Category: Weight loss > Wegovy
- Pack format: see product images for pack format
- Price: A$352.00 AUD, including GST where applicable
- Dispatch: Sydney, Australia-wide
Using Wegovy (semaglutide) — a weight‑loss medication in clinic practice
Weight-loss injections differ by active ingredient, dose step and pen format. Check the strength and dose schedule on this page against the prescribing protocol you follow, store pens as the manufacturer directs, and confirm the quantity needed for a full treatment period before ordering.
Ordering Wegovy (semaglutide) — a weight‑loss medication and related products
Compare Wegovy (semaglutide) — a weight‑loss medication with Saxenda injector pen, Fitaro Semaglutide Injection physiological regulator of appetite and caloric intake, Tizaro Tirzepatide 2.5mg/5mg/7.5mg control high blood sugar, or browse the full Weight loss catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for Wegovy (semaglutide) — a weight‑loss medication is covered in the reference article on Semaglutide, and Australian practitioners should confirm regulatory positionings with the TGA before use.
